Cue Biopharma, Inc. Quarterly Depreciation in USD from Q1 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Cue Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q3 2024.
Cue Biopharma, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, unchanged year-over-year.
Cue Biopharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $467K, a 18.8% decline year-over-year.
Cue Biopharma, Inc. annual Depreciation for 2023 was $545K, a 34.4% decline from 2022.
Cue Biopharma, Inc. annual Depreciation for 2022 was $831K, a 8.59% decline from 2021.
Cue Biopharma, Inc. annual Depreciation for 2021 was $909K, a 16.5% increase from 2020.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$467K	$100K	$0	0%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$467K	$100K	$0	0%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$467K	$96K	-$78K	-44.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$545K	$171K	-$30K	-14.9%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	$575K	$100K	-$98K	-49.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	$673K	$100K	-$112K	-52.8%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	$785K	$174K	-$46K	-20.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$831K	$201K	-$27.1K	-11.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$858K	$198K	-$34K	-14.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-03
Q2 2022	$892K	$212K	-$19K	-8.23%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$911K	$220K	+$2K	+0.92%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$909K	$228K	+$42.6K	+23%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-21
Q3 2021	$867K	$232K	+$33K	+16.6%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$834K	$231K	+$29K	+14.4%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$805K	$218K	+$24K	+12.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$781K	$186K	-$9.59K	-4.91%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-16
Q3 2020	$790K	$199K	+$5K	+2.58%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	$785K	$202K	-$3K	-1.46%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$788K	$194K	-$11K	-5.37%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	$799K	$195K	-$7.9K	-3.89%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-09
Q3 2019	$807K	$194K	-$1K	-0.51%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$808K	$205K	+$10K	+5.13%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$798K	$205K	+$38K	+22.8%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$760K	$203K			Oct 1, 2018	Dec 31, 2018	10-K	2020-03-12
Q3 2018		$195K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$195K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018		$167K	+$100K	+149%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q1 2017		$67K			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.